Literature DB >> 22057073

Comparing effects of clonazepam and zolpidem on sleep quality of patients on maintenance hemodialysis.

Simin Dashti-Khavidaki1, Nastaran Chamani, Hossein Khalili, Azita Hajhossein Talasaz, Farokhlegha Ahmadi, Mahboob Lessan-Pezeshki, Padideh Ghaeli, Shirin Dalili, Abbas Alimadadi.   

Abstract

INTRODUCTION: Poor sleep quality is very common among maintenance hemodialysis patients and has negative impacts on patients' quality of life. Benzodiazepines have traditionally been used in this population; however, they may induce physical dependence and sleep apnea. Nonbenzodiazepine hypnotic medications with less side effects are introduced as alternatives. This study was designed to compare the effect of zolpidem and clonazepam on sleep quality of hemodialysis patients.
MATERIALS AND METHODS: In a randomized crossover study on 23 hemodialysis patients, sleep quality was assessed using the Pittsburgh Sleep Quality Index at baseline, at the initiation of a 1-week washout period after a 2-week treatment with zolpidem (1 mg) and clonazepam (5 mg to 10 mg), and after the second 2 weeks of treatment. Patients who suffer from any concurrent situations that may affect sleep quality or psychiatric disorders and those on medications affecting sleep quality were excluded.
RESULTS: The prevalence of poor sleep quality was 87.8% of the 88 hemodialysis patients who were initially approached. There was a significant negative correlation between iron deficiency and poor sleep quality. Both clonazepam and zolpidem significantly improved sleep quality; however, clonazepam was more effective in decreasing the Pittsburgh Sleep Quality Index scores (P = .03). Zolpidem was better tolerated in the hemodialysis patients.
CONCLUSIONS: Clonazepam was more effective than zolpidem in the improvement of sleep quality of hemodialysis patients, while zolpidem was better tolerated in these patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057073

Source DB:  PubMed          Journal:  Iran J Kidney Dis        ISSN: 1735-8582            Impact factor:   0.892


  7 in total

1.  Design and implementation of a randomized crossover study of valproic acid and antiretroviral therapy to reduce the HIV reservoir.

Authors:  J P Routy; J B Angel; J N Spaans; B Trottier; D Rouleau; J G Baril; M Harris; S Trottier; J Singer; N Chomont; R P Sékaly; C L Tremblay
Journal:  HIV Clin Trials       Date:  2012 Nov-Dec

2.  Zolpidem Versus Trazodone Initiation and the Risk of Fall-Related Fractures among Individuals Receiving Maintenance Hemodialysis.

Authors:  Magdalene M Assimon; Jennifer E Flythe
Journal:  Clin J Am Soc Nephrol       Date:  2020-12-18       Impact factor: 8.237

3.  Sleep quality in patients on maintenance hemodialysis and peritoneal dialysis.

Authors:  Maryam Masoumi; Afsoon Emami Naini; Rozita Aghaghazvini; Babak Amra; Ali Gholamrezaei
Journal:  Int J Prev Med       Date:  2013-02

4.  Interventions for improving sleep quality in people with chronic kidney disease.

Authors:  Patrizia Natale; Marinella Ruospo; Valeria M Saglimbene; Suetonia C Palmer; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2019-05-26

Review 5.  Sleep Quality in Iranian Hemodialysis Patients: A Systematic Review and Meta-analysis.

Authors:  Masood Taheri Mirghaed; Razieh Sepehrian; Amir Rakhshan; HasanAbolghasem Gorji
Journal:  Iran J Nurs Midwifery Res       Date:  2019-11-07

6.  Effectiveness and safety profiling of zolpidem and acupressure in CKD associated pruritus: An interventional study.

Authors:  Inayat Ur Rehman; Raheel Ahmed; Aziz Ur Rahman; David Bin Chia Wu; Syed Munib; Yasar Shah; Nisar Ahmad Khan; Ateeq Ur Rehman; Learn Han Lee; Kok Gan Chan; Tahir Mehmood Khan
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.889

7.  A randomized controlled trial for effectiveness of zolpidem versus acupressure on sleep in hemodialysis patients having chronic kidney disease-associated pruritus.

Authors:  Inayat Ur Rehman; David Bin-Chia Wu; Raheel Ahmed; Nisar Ahmad Khan; Aziz Ur Rahman; Syed Munib; Learn Han Lee; Kok Gan Chan; Tahir Mehmood Khan
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.